Saturday, March 7, 2015

2015

1/31/15 - m-spike 1.4
2/17/15 - m-spike 1.5 to start study
  • began SAR650984 study. 
  • Includes 40mg dex and 25mg revlimid. 
  • Had a pretty serious reaction during infusion. 
    • Throat tightened (hard to swallow)
    • head stopped up, and chest tightness
    • Stopped treatment for an hour but then restarted and everything was fine. 
  • Zometa treatment 
2/24/15 - treatment, noticed immediately less pain in feet and knees, result of taking dex again. 
3/03/15 - treatment 
3/10/15 - treatment 
3/17/15 - m-spike 1.0 after 1 month of treatment 
4/17/15 - m-spike 0.7 after 2 months of treatment 
5/17/15 - m-spike 0.6 after 3 months of treatment 
5/14/15 - 5/18/15 admitted to hospital with pneumonia and para influenza
6/17/15 - m-spike 0.6 after 4 months of treatment
  • Zometa treatment 
7/17/15 - m-spike 0.6 again
8/17/15 - m-spike 0.4 !!   
9/01/15 - m-spike 0.5  

  • Zometa treatment
10/01/15 - m-spike 0.3
11/01/15 - m-spike 0.3
11/24/15 - m-spike 0.3 
  • Zometa treatment
  • SAR650984 is given a name: Isatuximab.
  • daratumumab (Darzalex) approved by FDA (close to Isatuximab)
  • Ixazomib (Ninlaro) (next gen of velcade, carfilzamib, but in pill form) approved by FDA
  • Elotuzumab (Empliciti) approved by FDA
12/22/15 - m-spike 0.2


No comments:

Post a Comment